Fındık, H. Et Al. 2019. Polymorphism ICAM-1 and Beta-3 Integrin Are Associated with the Development of Non-Small Cell Lung Cancer and the Prognostic Role of ICAM-1.. IASLC 2019 World Conference on Lung Cancer, Journal of Thoracic Oncology , (Barcelona, Spain), 706.

Fındık, H., YAYLIM, İ., DEMİRKOL, Ş., HAKAN, M. T., KÜÇÜKHÜSEYİN, Ö., Sarbay, I., ... TURNA, A.(2019). Polymorphism ICAM-1 and Beta-3 Integrin Are Associated with the Development of Non-Small Cell Lung Cancer and the Prognostic Role of ICAM-1. . IASLC 2019 World Conference on Lung Cancer, Journal of Thoracic Oncology (pp.706). Barcelona, Spain

Fındık, Hilal Et Al. "Polymorphism ICAM-1 and Beta-3 Integrin Are Associated with the Development of Non-Small Cell Lung Cancer and the Prognostic Role of ICAM-1.," IASLC 2019 World Conference on Lung Cancer, Journal of Thoracic Oncology, Barcelona, Spain, 2019

Fındık, Hilal Et Al. "Polymorphism ICAM-1 and Beta-3 Integrin Are Associated with the Development of Non-Small Cell Lung Cancer and the Prognostic Role of ICAM-1.." IASLC 2019 World Conference on Lung Cancer, Journal of Thoracic Oncology , Barcelona, Spain, pp.706, 2019

Fındık, H. Et Al. (2019) . "Polymorphism ICAM-1 and Beta-3 Integrin Are Associated with the Development of Non-Small Cell Lung Cancer and the Prognostic Role of ICAM-1.." IASLC 2019 World Conference on Lung Cancer, Journal of Thoracic Oncology , Barcelona, Spain, p.706.

@conferencepaper{conferencepaper, author={Hilal Fındık Et Al. }, title={Polymorphism ICAM-1 and Beta-3 Integrin Are Associated with the Development of Non-Small Cell Lung Cancer and the Prognostic Role of ICAM-1.}, congress name={IASLC 2019 World Conference on Lung Cancer, Journal of Thoracic Oncology}, city={Barcelona}, country={Spain}, year={2019}, pages={706} }